Trial intelligence / Profile preview

Midazolam versus zolpidem versus placebo for anxiety and pain in dental implant surgery

IRCT20171015036782N11Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in anxiety disorder and acute pain comparing Placebo, Midazolam and Zolpidem (3 arms). Primary endpoint: Pain intensity. Started Jun 2025; status: completed.

02

Drugs

midazolamzolpidem
03

Conditions

anxiety disorderacute pain

Beyond the preview

Go deeper on IRCT20171015036782N11.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171015036782N11.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call